source
- Definium's LSD pill shows positive results in late-stage anxiety trialDefinium Therapeutics reported that its pharmaceutical-grade LSD formulation, DT120, achieved positive outcomes in a late-stage study targeting generalized anxiety disorder. The trial used a 56-po…
- Definium’s oral LSD candidate DT120 shows strong anxiety reduction in Phase 3 trialDefinium Therapeutics reported that its single‑dose oral LSD candidate DT120 achieved a statistically significant reduction in anxiety symptoms in a Phase 3 study of generalized anxiety disorder. T…